Nicotine Replacement Therapy Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Electronic cigarettes for smoking cessation
CONCLUSIONS: There is high-certainty evidence that ECs with nicotine increase quit rates compared to NRT and moderate-certainty evidence that they increase quit rates compared to ECs without nicotine. Evidence comparing nicotine EC with usual care/no treatment also suggests benefit, but is less certain. More studies are needed to confirm the effect size. Confidence intervals were for the most part wide for data on AEs, SAEs and other safety markers, with no difference in AEs between nicotine and non-nicotine ECs nor between nicotine ECs and NRT. Overall incidence of SAEs was low across all study arms. We did not detect evi...
Source: Cochrane Database of Systematic Reviews - November 17, 2022 Category: General Medicine Authors: Jamie Hartmann-Boyce Nicola Lindson Ailsa R Butler Hayden McRobbie Chris Bullen Rachna Begh Annika Theodoulou Caitlin Notley Nancy A Rigotti Tari Turner Thomas R Fanshawe Peter Hajek Source Type: research

Smoking Cessation Interventions
Am Fam Physician. 2022 Nov;106(5):513-522.ABSTRACTIn the United States, 1 in 5 adults uses tobacco products. Cigarette smoking is the leading cause of preventable disease and death in the United States despite its known health effects. Although nearly one-half of people who smoke try to quit each year, only up to 1 in 20 who quit without support achieve abstinence for at least six months. All patients, including school-aged children and adolescents, should be asked if they smoke and offered evidence-based treatments for smoking cessation. Use of the 5 A's framework (ask, advise, assess, assist, arrange) can help clinicians...
Source: American Family Physician - November 15, 2022 Category: Primary Care Authors: Heidi L Gaddey MaryAnn Dakkak Nicole Marie Jackson Source Type: research

Most Smokers With SMI Don ’t Get Treated for Smoking Cessation, Study Finds
From 2005 to 2019, nearly 98% of smokers —including those with and without serious mental illness (SMI)—were not prescribed treatments for tobacco use disorder, according to astudy published yesterday inPsychiatric Services.“Pharmacotherapy is safe and effective for smokers with mental illness, and evidence shows that these medications improve outcomes without worsening psychiatric symptoms,” wrote Sarah White, M.S.P.H., of Johns Hopkins Bloomberg School of Public Health, Karly Murphy, M.D., M.H.S., of Johns Hopkin s School of Medicine, and colleagues. “However, estimates indicate that only 25% of specialty menta...
Source: Psychiatr News - November 10, 2022 Category: Psychiatry Tags: bupropion mental illness nicotine replacement therapy Psychiatric Services serious mental illness SMI smokers smoking cessation varenicline Source Type: research

Smoking Cessation Medication Prescribing for Smokers With and Without Mental Illness
CONCLUSIONS: System- and provider-level strategies to support evidence-based smoking cessation treatment for people with and without mental illness are needed.PMID:36349496 | DOI:10.1176/appi.ps.202100690 (Source: Psychiatric Services)
Source: Psychiatric Services - November 9, 2022 Category: Psychiatry Authors: Sarah A White Elizabeth Stone Karly A Murphy Gail L Daumit Emma E McGinty Source Type: research

Is There a Smoking Gun for Nicotine? A Review of the Role of Nicotine in Dermatologic Surgery
CONCLUSION Dermatologists should consider recommending nicotine replacement for smokers in the perioperative period. Evidence is lacking to determine safety in flaps. It is presumed based on animal studies that nicotine has a negative effect on flaps; however, it is likely less than tobacco. Weighing the risk of cessation failure without nicotine replacement versus nicotine replacement after flap is challenging. Electronic cigarettes should be discouraged as a means of NRT. (Source: Dermatologic Surgery)
Source: Dermatologic Surgery - November 1, 2022 Category: Dermatology Tags: Review Article Source Type: research

The value of compassionate support to address smoking: A qualitative study with people who experience severe mental illness
DISCUSSION: The findings underscore the enormity of the challenges that our targeted population face and the considerations needed for providing tobacco treatment to people who experience SMI. The data suggest that a tailored tobacco treatment intervention has the potential to assist people on a journey to quitting, and that compassionate support encapsulating a recovery-oriented approach is highly valued.CLINICAL TRIAL REGISTRATION: The Quitlink trial was registered with ANZCTR (www.anzctr.org.au): ACTRN12619000244101 prior to the accrual of the first participant and updated regularly as per registry guidelines.PMID:36276...
Source: Cancer Control - October 24, 2022 Category: Cancer & Oncology Authors: Kristen McCarter Melissa L McKinlay Nadine Cocks Catherine Brasier Laura Hayes Amanda L Baker David Castle Ron Borland Billie Bonevski Catherine Segan Peter J Kelly Alyna Turner Jill Williams John Attia Rohan Sweeney Sacha Filia Donita Baird Lisa Brophy Source Type: research

Pharmacological interventions on smoking cessation: A systematic review and network meta-analysis
Conclusion: Most pharmacological interventions demonstrated a benefit in smoking cessation compared with placebo, whether monotherapy or combination therapy. Moreover, confirmed evidence suggested that some combination treatments, such as varenicline plus bupropion and nicotine replacement therapy plus mecamylamine have a higher probability of being the best smoking cessation in (Source: Frontiers in Pharmacology)
Source: Frontiers in Pharmacology - October 24, 2022 Category: Drugs & Pharmacology Source Type: research

Effect of financial voucher incentives provided with UK stop smoking services on the cessation of smoking in pregnant women (CPIT III): pragmatic, multicentre, single blinded, phase 3, randomised controlled trial
CONCLUSIONS: The offer of up to £400 of financial voucher incentives to stop smoking during pregnancy as an addition to current UK stop smoking services is highly effective. This bolt-on intervention supports new guidance from the UK National Institute for Health and Care Excellence, which includes the addition of financial incentives to support pregnant women to stop smoking. Continuing incentives to 12 months after birth is being examined to prevent relapse.TRIAL REGISTRATION: ISRCTN Registry ISRCTN15236311.PMID:36261162 | DOI:10.1136/bmj-2022-071522 (Source: Cancer Control)
Source: Cancer Control - October 19, 2022 Category: Cancer & Oncology Authors: David Tappin Lesley Sinclair Frank Kee Margaret McFadden Lyn Robinson-Smith Alex Mitchell Ada Keding Judith Watson Sinead Watson Alison Dick David Torgerson Catherine Hewitt Jennifer McKell Pat Hoddinott Fiona M Harris Kathleen A Boyd Nicola McMeekin Mich Source Type: research

Koori Quit Pack mailout smoking cessation support for Aboriginal and Torres Strait Islander people who smoke: a feasibility study protocol
Introduction Smoking remains the leading preventable cause of death for Aboriginal and Torres Strait Islander people in Australia. Aboriginal and Torres Strait Islander people who smoke are more likely to make a quit attempt than their non-Aboriginal counterparts but less likely to sustain the quit attempt. There is little available evidence specifically for and by Indigenous peoples to inform best practice smoking cessation care. The provision of a free Koori Quit Pack with optional nicotine replacement therapy sent by mail may be a feasible, acceptable and effective way to access stop smoking support for Aboriginal and T...
Source: BMJ Open - October 13, 2022 Category: General Medicine Authors: Kennedy, M., Mersha, A. G., Maddox, R., Chamberlain, C., Maidment, S., O'Mara, P., Segan, C., Hunt, M., Clarke, K., Donaldson, B., Bonevski, B. Tags: Open access, Public health Source Type: research